Who is sponsoring NCT04265469?

NCT04265469 is sponsored by Istanbul Medeniyet University.

What drugs are being tested in NCT04265469?

Interventions in NCT04265469: Diabetic foot education.

What condition does NCT04265469 study?

NCT04265469 studies Diabetic Foot, Mobile Application, Patient Education.

Is NCT04265469 still recruiting?

NCT04265469 is currently completed. Last updated 11 February 2020.

Last reviewed 2020-02-11 · How we verify

NCT04265469

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mobile Application For Educating Diabetics About Foot Care

Completed NA Last updated 11 February 2020

What this trial tests

NA trial testing Diabetic foot education in Diabetic Foot, Mobile Application, Patient Education in 130 participants. Completed in 7 November 2017.

Timeline

10 February 2016

Primary endpoint
7 February 2017

7 November 2017

Quick facts

Lead sponsor	Istanbul Medeniyet University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	130
Start date	10 February 2016
Primary completion	7 February 2017
Estimated completion	7 November 2017

Drugs / interventions tested

Diabetic foot education

Conditions studied

Diabetic Foot, Mobile Application, Patient Education — all drugs for Diabetic Foot, Mobile Application, Patient Education →

Sponsor

Istanbul Medeniyet University

Who can join

Adults 18 to 70, any sex, with Diabetic Foot, Mobile Application, Patient Education. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Purpose: Our aim was to develop a training program on the mobile application and to assess the effect of this training on the participants' knowledge about foot care, their self-efficacy and their behavior levels.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Istanbul Medeniyet University trials

Trials by the same sponsor.

NCT07478380 — Transcutaneous pO₂ Monitoring in PICU · recruiting
NCT07368244 — Turkish Translation and Content Validity of the Nottwil Environmental Factors Inventory (NEFI) in Persons With Spinal Co · recruiting
NCT07179731 — Comparison of the Effects of External Oblique Intercostal Plane Block, Subcostal Transverse Abdominis Plane Block, and T · NA · not yet recruiting
NCT07241455 — Validity of the Children's Chelsea Critical Care Physical Assessment Tool (cCPAx-TR) in Turkish Pediatric Intensive Care · completed
NCT07426497 — Osteopathic Manual Therapy vs Ganglion Impar Block for Chronic Coccydynia · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04265469 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Istanbul Medeniyet University
Last refreshed: 11 February 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04265469.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing